Purpose: We evaluated the ability of the phosphodiesterase-5 inhibitor vardenafil to increase prostate microcirculation during power Doppler ultrasound. We also evaluated the results of contrast and vardenafil enhanced targeted biopsies compared to those of standard 12-core random biopsies to detect cancer. Materials and Methods: Between May 2008 and January 2010, 150 consecutive patients with prostate specific antigen more than 4 ng/ml at first diagnosis with negative digital rectal examination and transrectal ultrasound, and no clinical history of prostatitis underwent contrast enhanced power Doppler ultrasound (bolus injection of 2.4 ml SonoVue® contrast agent), followed by vardenafil enhanced power Doppler ultrasound (1 hour after oral administration of vardenafil 20 mg). All patients underwent standard 12-core transrectal ultrasound guided random prostate biopsy plus 1 further sampling from each suspected hypervascular lesion detected by contrast and vardenafil enhanced power Doppler ultrasound. Results: Prostate cancer was detected in 44 patients (29.3%). Contrast and vardenafil enhanced power Doppler ultrasound detected suspicious, contrast enhanced and vardenafil enhanced areas in 112 (74.6%) and 110 patients (73.3%), and was diagnostic for cancer in 32 (28.5%) and 42 (38%), respectively. Analysis of standard technique, and contrast and vardenafil enhanced power Doppler ultrasound findings by biopsy core showed significantly higher detection using vardenafil vs contrast enhanced power Doppler ultrasound and standard technique (41.2% vs 22.7% and 8.1%, p _0.005 and _0.001, respectively). The detection rate of standard plus contrast or vardenafil enhanced power Doppler ultrasound was 10% and 11.7% (p not significant). Conclusions: Vardenafil enhanced power Doppler ultrasound enables excellent visualization of the microvasculature associated with cancer and can improve the detection rate compared to contrast enhanced power Doppler ultrasound and the random technique.

Simple Enucleation Is Equivalent to Traditional Partial Nephrectomy for Renal Cell Carcinoma : Results of a Non-randomized, Retrospective, Comparative Study / Minervini A; Ficarra V; Rocco F; Antonelli A; Bestini R; Carmignani G; Cosciani Cunico S; Fontana D; Longo N; Martorana; Mirone V; Morgia G; Novara G; Roscigno M; Schiavina R; Serni S; Simeone C; Simonato A; Siracusano S; Volpe A; Zattoni F; Zucchi A; Carini M. - In: THE JOURNAL OF UROLOGY. - ISSN 0022-5347. - STAMPA. - 185:(2011), pp. 1604-1610. [10.1016/j.juro.2010.12.048]

Simple Enucleation Is Equivalent to Traditional Partial Nephrectomy for Renal Cell Carcinoma : Results of a Non-randomized, Retrospective, Comparative Study.

MINERVINI, ANDREA;SERNI, SERGIO;CARINI, MARCO
2011

Abstract

Purpose: We evaluated the ability of the phosphodiesterase-5 inhibitor vardenafil to increase prostate microcirculation during power Doppler ultrasound. We also evaluated the results of contrast and vardenafil enhanced targeted biopsies compared to those of standard 12-core random biopsies to detect cancer. Materials and Methods: Between May 2008 and January 2010, 150 consecutive patients with prostate specific antigen more than 4 ng/ml at first diagnosis with negative digital rectal examination and transrectal ultrasound, and no clinical history of prostatitis underwent contrast enhanced power Doppler ultrasound (bolus injection of 2.4 ml SonoVue® contrast agent), followed by vardenafil enhanced power Doppler ultrasound (1 hour after oral administration of vardenafil 20 mg). All patients underwent standard 12-core transrectal ultrasound guided random prostate biopsy plus 1 further sampling from each suspected hypervascular lesion detected by contrast and vardenafil enhanced power Doppler ultrasound. Results: Prostate cancer was detected in 44 patients (29.3%). Contrast and vardenafil enhanced power Doppler ultrasound detected suspicious, contrast enhanced and vardenafil enhanced areas in 112 (74.6%) and 110 patients (73.3%), and was diagnostic for cancer in 32 (28.5%) and 42 (38%), respectively. Analysis of standard technique, and contrast and vardenafil enhanced power Doppler ultrasound findings by biopsy core showed significantly higher detection using vardenafil vs contrast enhanced power Doppler ultrasound and standard technique (41.2% vs 22.7% and 8.1%, p _0.005 and _0.001, respectively). The detection rate of standard plus contrast or vardenafil enhanced power Doppler ultrasound was 10% and 11.7% (p not significant). Conclusions: Vardenafil enhanced power Doppler ultrasound enables excellent visualization of the microvasculature associated with cancer and can improve the detection rate compared to contrast enhanced power Doppler ultrasound and the random technique.
2011
185
1604
1610
Goal 3: Good health and well-being
Minervini A; Ficarra V; Rocco F; Antonelli A; Bestini R; Carmignani G; Cosciani Cunico S; Fontana D; Longo N; Martorana; Mirone V; Morgia G; Novara G; Roscigno M; Schiavina R; Serni S; Simeone C; Simonato A; Siracusano S; Volpe A; Zattoni F; Zucchi A; Carini M
File in questo prodotto:
File Dimensione Formato  
fulltext minervini j urol 2011.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: DRM non definito
Dimensione 255.09 kB
Formato Adobe PDF
255.09 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/675548
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 149
  • ???jsp.display-item.citation.isi??? 138
social impact